A detailed history of Iht Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Iht Wealth Management, LLC holds 1,021 shares of BIIB stock, worth $177,439. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,021
Holding current value
$177,439
% of portfolio
0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $194,520 - $241,691
1,021 New
1,021 $236,000
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $215,278 - $271,239
-1,111 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $7,389 - $9,496
-33 Reduced 2.88%
1,111 $267,000
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $167,530 - $218,477
-592 Reduced 34.1%
1,144 $324,000
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $219,114 - $350,844
846 Added 95.06%
1,736 $601,000
Q1 2021

May 18, 2021

SELL
$242.95 - $284.63 $10,446 - $12,239
-43 Reduced 4.61%
890 $249,000
Q4 2020

Feb 17, 2021

BUY
$236.26 - $355.63 $29,296 - $44,098
124 Added 15.33%
933 $228,000
Q3 2020

Nov 19, 2020

SELL
$264.77 - $305.71 $264 - $305
-1 Reduced 0.12%
809 $229,000
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $14,226 - $18,840
-55 Reduced 6.36%
810 $217,000
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $4,301 - $5,456
16 Added 1.88%
865 $274,000
Q4 2019

Feb 18, 2020

BUY
$220.06 - $304.07 $186,830 - $258,155
849 New
849 $252,000
Q3 2019

Nov 15, 2019

SELL
$217.44 - $243.88 $206,568 - $231,686
-950 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$219.29 - $241.72 $208,325 - $229,634
950 New
950 $222,000
Q2 2018

Aug 13, 2018

SELL
$257.52 - $306.91 $59,487 - $70,896
-231 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $6,503 - $9,197
-25 Reduced 9.77%
231 $62,000
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $5,537 - $6,202
-18 Reduced 6.57%
256 $84,000
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $77,035 - $90,335
274
274 $90,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.